Entity Common Stock, Shares Outstanding of Enliven Therapeutics, Inc. from 01 May 2020 to 19 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Enliven Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 May 2020 to 19 Feb 2026.
  • Enliven Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 19 Feb 2026 was 59,800,406, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Enliven Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 59,800,406 +10,731,148 +22% 19 Feb 2026 10-K 03 Mar 2026 2025 FY
Q3 2025 59,347,317 +10,488,151 +21% 31 Oct 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 59,235,547 +11,998,340 +25% 31 Jul 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 49,069,258 +7,721,626 +19% 01 May 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 48,859,166 +7,647,193 +19% 01 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 47,237,207 +6,086,096 +15% 01 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 41,347,632 +232,837 +0.57% 01 Mar 2024 10-K 14 Mar 2024 2023 FY
Q3 2023 41,211,973 +14,924,709 +57% 01 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 41,151,111 +14,863,847 +57% 01 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 41,114,795 +14,839,073 +56% 01 May 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 26,233,901 06 Feb 2023 10-K 10 Feb 2023 2022 FY
Q3 2022 26,287,264 +11,542 +0.04% 20 Oct 2022 10-Q 25 Oct 2022 2022 Q3
Q2 2022 26,287,264 +39,994 +0.15% 01 Aug 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 26,275,722 +8,700,474 +50% 30 Apr 2022 10-Q 06 May 2022 2022 Q1
Q3 2021 26,275,722 +8,868,281 +51% 29 Oct 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 26,247,270 +8,922,534 +52% 02 Aug 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 17,575,248 +294,783 +1.7% 01 Mar 2021 10-K 05 Mar 2021 2020 FY
Q3 2020 17,407,441 30 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 17,324,736 31 Jul 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 17,280,465 01 May 2020 10-Q 07 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.